Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 13, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Hepatitis BHepatitisHepatitis, Viral, HumanHepatitis B Immunization
Interventions
BIOLOGICAL

Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed).

"The primary immunisation consists of 4 separate 0.5 ml doses administered at the following schedule:~1 month, 2 months and 6 months from the date of the first dose. Once initiated, the primary course of vaccination at 0, 1, 2 and 6 months should be completed with Fendrix, and not with other commercially available HBV vaccine"

Trial Locations (11)

24080

Complejo Asistencial Universitario de León, León

28007

Hospital Universitario Gregorio Marañón, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

34005

Complejo Asistencial Universitario de Palencia, Palencia

37007

Complejo Asistencial Universitario de Salamanca, Salamanca

47003

Hospital Clinico Universitario de Valladolid, Valladolid

49022

Complejo Asistencial de Zamora, Zamora

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Spanish Clinical Research Network - SCReN

NETWORK

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER

NCT03410953 - Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines | Biotech Hunter | Biotech Hunter